PUR finds more evidence of SEDEX style zinc-lead at Bluebush


Published 12-OCT-2017 16:12 P.M.


2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

Only two days after announcing promising assay results from the first hole of its five hole Bluebush Zinc Project exploration program, Pursuit Minerals (ASX:PUR) advised that the third hole intersected 20 metres of zinc and lead mineralisation.

These extensive widths were also encountered in the first hole which supported management’s belief that the Bluebush deposit was a major SEDEX style zinc-lead system.

Bluebush along with the Paperbark and Coober Pedy projects were acquired from Tech Australia. Both Bluebush and Paperbark are located within the Bluebush Basin in the Mt Isa region of Queensland, which is classified as a second-order sub-basin analogous to the sedimentary basin at the Century Zinc Mine, where zinc mineralisation extends over an area of 120 square kilometres.

Bluebush consists of two exploration permits covering an area of 214 square kilometres. As indicated below, the third drill hole was looking to test for the formation of a SEDEX style mineralisation zone in the north-east quadrant of an intersection between the Boga and V8 faults.

Pursuit minerals drill holes

Any news is speculative at this stage therefore investors considering this stock for their portfolio, should seek professional financial advice.

This hole is interpreted to be positioned in the same sub-basin as an historical drill hole which returned 11 metres grading 2.3 per cent zinc and 0.1 per cent lead.

Drilling operational issues prevented sampling of a 12 metre interval of the third drill hole from the basement interface at 163 metres until 175 metres downhole depth. Consequently, the zinc and lead mineralisation intersected could be up to 12 metres thicker.

From a broader perspective, and also taking into account historical data, highly significant zinc and lead mineralisation has now been intersected along and across a strike distance of 1400 metres.

Importantly, the higher grade mineralisation delineated in the third hole suggests that exploration closer to the Boga Fault Zone could unveil a source of high-grade ore.

Management well positioned for 2018 drilling campaign

In referring to the geological trends that exist in that region, management said, “World-class zinc ore bodies at Century and McArthur River both have fault controlled mineralisation, similar to what was intersected in drill hole BB04-17 (see above), up sequence, but in close proximity to the main orebodies”.

These two important outcomes from holes BB03-17 and BB04-17, and the fact that the Boga Fault Zone has been confirmed as an important structure in controlling the higher-grade zinc and lead mineralisation at Bluebush, have significantly advanced management’s understanding of the zinc mineralisation across the entire Bluebush sub-basin.

Furthermore, the drilling completed in 2017 at Bluebush has allowed PUR to define a clear focus for follow up drilling to be completed in 2018, which will aim to determine if a major zinc deposit occurs between, and in close proximity to, drill holes BB03-17 and BB04-17.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.


Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free